In this podcast, expert clinicians will discuss the latest evidence regarding the selection of antiretroviral regimens patients with HIV who are highly experienced.
In this podcast, expert clinicians will discuss the use of 3-drug versus 2-drug antiretroviral regimens in terms of efficacy, safety, and meeting the needs of individual patients with HIV.
In this podcast, expert clinicians will discuss the latest evidence-based guidelines regarding the early detection and treatment of HIV.
In this podcast, expert clinicians will discuss how to recognize geographic disparities for pre-exposure prophylaxis (PrEP) as well as how HIV PrEP can be successfully implemented into clinical practice using an interprofessional approach.
In this podcast, expert clinicians will discuss the challenges of antimicrobial stewardship in the COVID-19 era.
In this podcast, expert clinicians will discuss the implications of Gram-negative bacteria on complicated intra-abdominal infections.
In this podcast, expert clinicians will discuss a patient case focusing on Gram-negative pathogens in UTIs.
In this podcast, expert clinicians will discuss best practices for the management of VAP caused by Gram-negative pathogens.
In this podcast, expert clinicians will discuss treatment considerations for a patient with HAP due to gram-negative bacteria.
In this podcast, expert clinicians will discuss the use of 3-drug versus 2-drug antiretroviral regimens in terms of efficacy, safety, and meeting the needs of individual patients with HIV.
In this podcast, expert clinicians will discuss the need for antiretroviral treatment regimens that improve patient adherence to therapy.
In this podcast, expert clinicians will discuss the latest evidence regarding the selection of antiretroviral regimens in aging patients with HIV.
In this podcast, expert clinicians will discuss how pre-exposure prophylaxis (PrEP) for HIV can be successfully implemented into clinical practice using an interprofessional approach.
In this podcast, expert clinicians will discuss clinical evidence of HABP/VABP therapies used to treat gram-negative pathogens.
In this podcast, expert clinicians will discuss patterns of gram-negative resistance in HABP and VABP.
In this podcast, expert clinicians will discuss the burden of HABP and VABP secondary to gram-negative pathogens.
In this podcast, expert clinicians will discuss practice-based advances that may improve the consistent use of pre-exposure prophylaxis. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDisease6
In this podcast, expert clinicians will discuss the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence to prescribed regimens. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E5
In this podcast, expert clinicians will discuss the management of patients with HIV who are highly treatment-experienced. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E4
In this podcast, expert clinicians will discuss how to incorporate individualized ART regimens to improve outcomes in patients with HIV and comorbidities. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E3
In this podcast, expert clinicians will discuss current and prospective use of 2-drug regimens in the treatment of HIV. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E2
In this podcast, expert clinicians will discuss recent guideline revisions regarding the use of ART in different patient populations. For CME Credit, complete activity here: https://tinyurl.com/InfectiousDiseaseS1E1
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of six podcasts. The faculty of this program will explore various aspects of HIV management, including recent guideline revisions, use of 2-drug regimens, individualizing ART regimens in pat...
